309. Progressive myoclonus epilepsy Clinical trials / Disease details
Clinical trials : 11 / Drugs : 15 - (DrugBank : 2) / Drug target genes : 4 - Drug target pathways : 9
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03351569 (ClinicalTrials.gov) | December 9, 2015 | 27/10/2017 | Intravenous Immunoglobulin for Unverricht-Lundborg Disease. | Intravenous Immunoglobulin for Unverricht-Lundborg Disease: Single-patient Trial. | Unverricht-Lundborg Disease | Drug: Intravenous immunoglobulin | Azienda Socio Sanitaria Territoriale di Mantova | NULL | Active, not recruiting | 18 Years | 25 Years | Male | 1 | Phase 3 | NULL |